oleic acid has been researched along with exenatide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brindamour, LJ; Habener, JF; Liu, Z; Stanojevic, V | 1 |
| McMahon Tobin, GA; Rouse, RL; Zhang, LW | 1 |
| Chen-Liaw, AY; Gomez, G; Hammel, G | 1 |
| Al-Akl, NS; Arredouani, A; Errafii, K; Khalifa, O | 1 |
4 other study(ies) available for oleic acid and exenatide
| Article | Year |
|---|---|
GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity.
Topics: Adenosine Triphosphate; Apoptosis; Cell Survival; Cells, Cultured; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Hydrogen Peroxide; Insulin; Insulin Secretion; Insulin-Secreting Cells; Membrane Potential, Mitochondrial; Oleic Acid; Oxidative Stress; Peptide Fragments; Peptides; Receptors, Glucagon; tert-Butylhydroperoxide; Venoms | 2012 |
Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line.
Topics: Acinar Cells; Animals; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endosomes; Exenatide; Fluorescent Antibody Technique; Glucagon-Like Peptide-1 Receptor; Glucose; Islets of Langerhans; Microscopy, Confocal; Oleic Acid; Oncogene Protein v-akt; Pancreatic Ducts; Pancreatic Neoplasms; Peptides; Phosphorylation; Rats; Receptors, Glucagon; Stimulation, Chemical; Vacuoles; Venoms | 2012 |
Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Exenatide; Fatty Liver; Glucagon-Like Peptide 1; Hep G2 Cells; Hepatocytes; Humans; Isoquinolines; Linoleic Acid; Lipogenesis; Liver Neoplasms; Oleic Acid; Pancreas; Peptides; Sulfonamides; Triglycerides; Venoms | 2017 |
Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway.
Topics: Exenatide; Fatty Acid-Binding Proteins; Fatty Liver; Glucagon-Like Peptide-1 Receptor; Hep G2 Cells; Hepatocyte Nuclear Factor 3-alpha; Humans; In Vitro Techniques; Lipid Metabolism; Lipogenesis; Models, Biological; Oleic Acid; Protective Agents; Sterol Regulatory Element Binding Protein 1; Transcription Factor 4; Wnt Signaling Pathway | 2022 |